• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Contemporary Non-hormonal Therapies for the Management of Vasomotor Symptoms Associated with Menopause: A Literature Review.更年期血管舒缩症状管理的当代非激素疗法:文献综述
touchREV Endocrinol. 2021 Nov;17(2):133-137. doi: 10.17925/EE.2021.17.2.133. Epub 2021 Oct 13.
2
Nonpharmacological therapies for the management of menopausal vasomotor symptoms in breast cancer survivors.乳腺癌幸存者绝经期血管舒缩症状管理的非药物治疗。
Support Care Cancer. 2021 Mar;29(3):1183-1193. doi: 10.1007/s00520-020-05754-w. Epub 2020 Sep 17.
3
Psychosocial and socioeconomic burden of vasomotor symptoms in menopause: a comprehensive review.更年期血管舒缩症状的心理社会和社会经济负担:一项综合综述
Health Qual Life Outcomes. 2005 Aug 5;3:47. doi: 10.1186/1477-7525-3-47.
4
Non-hormonal pharmacological interventions for managing vasomotor symptoms-how can we help: 2024 landscape.非激素药理学干预措施管理血管舒缩症状——我们能如何提供帮助:2024 年前景。
Eur J Obstet Gynecol Reprod Biol. 2024 Nov;302:141-148. doi: 10.1016/j.ejogrb.2024.09.013. Epub 2024 Sep 12.
5
Non-oestrogen-based and complementary therapies for menopause.非雌激素类及补充疗法治疗更年期。
Best Pract Res Clin Endocrinol Metab. 2024 Jan;38(1):101819. doi: 10.1016/j.beem.2023.101819. Epub 2023 Aug 25.
6
Neurokinin 3 Receptor Antagonists Compared With Serotonin Norepinephrine Reuptake Inhibitors for Non-Hormonal Treatment of Menopausal Hot Flushes: A Systematic Qualitative Review.神经激肽 3 受体拮抗剂与 5-羟色胺去甲肾上腺素再摄取抑制剂治疗绝经相关热潮红的非激素治疗比较:系统定性评价。
Adv Ther. 2021 Oct;38(10):5025-5045. doi: 10.1007/s12325-021-01900-w. Epub 2021 Sep 12.
7
Neurokinin 3 Receptor Antagonism: A Novel Treatment for Menopausal Hot Flushes.神经激肽 3 受体拮抗剂:治疗更年期热潮红的新方法。
Neuroendocrinology. 2019;109(3):242-248. doi: 10.1159/000495889. Epub 2018 Nov 30.
8
An overview of menopause associated vasomotor symptoms and options available in its management.绝经相关血管舒缩症状概述及其管理可用选项。
Niger J Med. 2013 Jan-Mar;22(1):7-14.
9
Management of Early Menopause/Premature Ovarian Insufficiency in Women with or at High Risk of Breast Cancer.乳腺癌患者或高危女性的早期绝经/卵巢早衰管理
Semin Reprod Med. 2020 Sep;38(4-05):309-314. doi: 10.1055/s-0041-1726467. Epub 2021 Mar 31.
10
Managing vasomotor symptoms effectively without hormones.有效管理血管舒缩症状而不使用激素。
Climacteric. 2020 Dec;23(6):532-538. doi: 10.1080/13697137.2020.1789093. Epub 2020 Jul 22.

引用本文的文献

1
Nonhormonal Pharmacotherapies for the Treatment of Postmenopausal Vasomotor Symptoms.用于治疗绝经后血管舒缩症状的非激素药物疗法。
Cureus. 2024 Jan 17;16(1):e52467. doi: 10.7759/cureus.52467. eCollection 2024 Jan.
2
Specialty Care and Counselling about Hereditary Cancer Risk Improves Adherence to Cancer Screening and Prevention in Newfoundland and Labrador Patients with Pathogenic Variants: A Population-Based Retrospective Cohort Study.特殊护理和遗传性癌症风险咨询可提高纽芬兰和拉布拉多携带致病性变异患者的癌症筛查和预防依从性:基于人群的回顾性队列研究。
Curr Oncol. 2023 Oct 22;30(10):9367-9381. doi: 10.3390/curroncol30100678.
3
Neurokinin 1/3 receptor antagonists for menopausal women: A current systematic review and insights into the investigational non-hormonal therapy.神经激肽 1/3 受体拮抗剂用于围绝经期女性:当前系统评价及对探索性非激素治疗的深入了解。
Medicine (Baltimore). 2023 Jun 9;102(23):e33978. doi: 10.1097/MD.0000000000033978.
4
Vasomotor Symptoms During Menopause: A Practical Guide on Current Treatments and Future Perspectives.更年期血管舒缩症状:当前治疗方法及未来展望实用指南
Int J Womens Health. 2023 Feb 14;15:273-287. doi: 10.2147/IJWH.S365808. eCollection 2023.

本文引用的文献

1
Postmenopausal Hormone Therapy-Local and Systemic: A Pharmacologic Perspective.绝经后激素治疗 - 局部和全身:药理学视角。
J Clin Pharmacol. 2020 Dec;60 Suppl 2:S74-S85. doi: 10.1002/jcph.1740.
2
Menopause Transition and Cardiovascular Disease Risk: Implications for Timing of Early Prevention: A Scientific Statement From the American Heart Association.绝经过渡期与心血管疾病风险:早期预防时机的影响——美国心脏协会科学声明。
Circulation. 2020 Dec 22;142(25):e506-e532. doi: 10.1161/CIR.0000000000000912. Epub 2020 Nov 30.
3
Effect of the neurokinin 3 receptor antagonist fezolinetant on patient-reported outcomes in postmenopausal women with vasomotor symptoms: results of a randomized, placebo-controlled, double-blind, dose-ranging study (VESTA).神经激肽 3 受体拮抗剂 fezolinetant 对绝经后血管舒缩症状患者报告结局的影响:一项随机、安慰剂对照、双盲、剂量范围研究(VESTA)的结果。
Menopause. 2020 Dec;27(12):1350-1356. doi: 10.1097/GME.0000000000001621.
4
Oxybutynin vs Placebo for Hot Flashes in Women With or Without Breast Cancer: A Randomized, Double-Blind Clinical Trial (ACCRU SC-1603).奥昔布宁与安慰剂治疗有或无乳腺癌女性潮热的随机双盲临床试验(ACCRU SC - 1603)
JNCI Cancer Spectr. 2019 Oct 21;4(1):pkz088. doi: 10.1093/jncics/pkz088. eCollection 2020 Feb.
5
A phase 2b, randomized, placebo-controlled, double-blind, dose-ranging study of the neurokinin 3 receptor antagonist fezolinetant for vasomotor symptoms associated with menopause.一项评估神经激肽 3 受体拮抗剂 fezolinetant 治疗与绝经期相关血管舒缩症状的 2b 期、随机、安慰剂对照、双盲、剂量范围研究。
Menopause. 2020 Apr;27(4):382-392. doi: 10.1097/GME.0000000000001510.
6
Effects of NT-814, a dual neurokinin 1 and 3 receptor antagonist, on vasomotor symptoms in postmenopausal women: a placebo-controlled, randomized trial.NT-814,一种双重神经激肽 1 和 3 受体拮抗剂,对绝经后妇女血管舒缩症状的影响:一项安慰剂对照、随机试验。
Menopause. 2020 May;27(5):498-505. doi: 10.1097/GME.0000000000001500.
7
Gabapentin for the treatment of hot flushes in menopause: a meta-analysis.加巴喷丁治疗围绝经期热潮红:一项荟萃分析。
Menopause. 2020 Apr;27(4):485-493. doi: 10.1097/GME.0000000000001491.
8
Hormone Therapy for Postmenopausal Women.绝经后女性的激素治疗
N Engl J Med. 2020 Jan 30;382(5):446-455. doi: 10.1056/NEJMcp1714787.
9
Efficacy and safety of gabapentin and pregabalin in patients with vasomotor symptoms: a systematic review and meta-analysis.加巴喷丁和普瑞巴林治疗血管舒缩症状患者的疗效和安全性:系统评价和荟萃分析。
Am J Obstet Gynecol. 2020 Jun;222(6):564-579.e12. doi: 10.1016/j.ajog.2019.12.011. Epub 2019 Dec 20.
10
Treatment of Menopausal Vasomotor Symptoms With Fezolinetant, a Neurokinin 3 Receptor Antagonist: A Phase 2a Trial.用神经激肽 3 受体拮抗剂非佐利奈坦治疗绝经血管舒缩症状:一项 2a 期试验。
J Clin Endocrinol Metab. 2019 Dec 1;104(12):5893-5905. doi: 10.1210/jc.2019-00677.

更年期血管舒缩症状管理的当代非激素疗法:文献综述

Contemporary Non-hormonal Therapies for the Management of Vasomotor Symptoms Associated with Menopause: A Literature Review.

作者信息

Sahni Sabrina, Lobo-Romero Angie, Smith Taryn

机构信息

Division of General Internal Medicine, Jacoby Center for Breast Health, Mayo Clinic, Jacksonville, FL, USA.

Division of General Internal Medicine, Women's Health, Mayo Clinic Rochester, MN, USA.

出版信息

touchREV Endocrinol. 2021 Nov;17(2):133-137. doi: 10.17925/EE.2021.17.2.133. Epub 2021 Oct 13.

DOI:10.17925/EE.2021.17.2.133
PMID:35118459
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8676100/
Abstract

Nearly 75% of all menopausal women experience bothersome vasomotor symptoms including hot flushes and night sweats. Yet vasomotor symptoms continue to be an undertreated and underdiagnosed symptom of menopause which can negatively affect a woman's overall quality of life. While hormone therapy has been widely utilized to ameliorate hot flushes, not all women are candidates for use, especially those with increased risk of cardiovascular disease, thromboembolic disease, and/or women at an increased risk of certain hormone-dependent cancers. The current literature provides strong evidence for non-hormonal therapies in women who experience vasomotor symptoms. This article reviews the evidence for the use of non-hormonal pharmacologic therapies for the treatment of menopausal symptoms including antidepressants, gabapentinoids, clonidine and anticholinergics. We also review data on emerging therapies including the latest evidence on neurokinin-1 and -3 antagonists. These therapies should be considered when hormonal options are contraindicated and/or not preferred by the patient. While there are many options available, clinicians should individualize therapy based on the patient's needs and goals while mitigating bothersome side effects.

摘要

近75%的绝经后女性会出现令人困扰的血管舒缩症状,包括潮热和盗汗。然而,血管舒缩症状仍然是绝经的一种治疗不足和诊断不足的症状,会对女性的整体生活质量产生负面影响。虽然激素疗法已被广泛用于改善潮热,但并非所有女性都适合使用,尤其是那些心血管疾病、血栓栓塞性疾病风险增加的女性,以及某些激素依赖性癌症风险增加的女性。目前的文献为有血管舒缩症状的女性采用非激素疗法提供了有力证据。本文综述了使用非激素药物疗法治疗绝经症状的证据,包括抗抑郁药、加巴喷丁类药物、可乐定和抗胆碱能药物。我们还综述了新兴疗法的数据,包括神经激肽-1和-3拮抗剂的最新证据。当激素治疗方案存在禁忌和/或患者不倾向于使用时,应考虑这些疗法。虽然有多种选择,但临床医生应根据患者的需求和目标个体化治疗,同时减轻令人困扰的副作用。